Published in Front Neurosci on April 08, 2013
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev (2016) 0.96
Cyclic AMP sensor EPAC proteins and energy homeostasis. Trends Endocrinol Metab (2013) 0.95
Adipokines, diabetes and atherosclerosis: an inflammatory association. Front Physiol (2015) 0.94
Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice. Int J Clin Exp Pathol (2015) 0.90
A comparative controlled trial comparing the effects of yoga and walking for overweight and obese adults. Med Sci Monit (2014) 0.88
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Sci OA (2015) 0.81
Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver (2016) 0.78
Leptin-induced mitochondrial fusion mediates hepatic lipid accumulation. Int J Obes (Lond) (2015) 0.78
Combined elevated midpregnancy tumor necrosis factor alpha and hyperlipidemia in pregnancies resulting in early preterm birth. Am J Obstet Gynecol (2014) 0.77
The history of diabetes mellitus. Sultan Qaboos Univ Med J (2013) 0.76
Chronic Hyperinsulinaemic Hypoglycaemia in Rats Is Accompanied by Increased Body Weight, Hyperleptinaemia, and Decreased Neuronal Glucose Transporter Levels in the Brain. Int J Endocrinol (2017) 0.75
Randomized Trial Testing the Effects of Eating Frequency on Two Hormonal Biomarkers of Metabolism and Energy Balance. Nutr Cancer (2016) 0.75
Central regulation of food intake, body weight, energy expenditure, and glucose homeostasis. Front Neurosci (2014) 0.75
Rhythms in the endocrine system of fish: a review. J Comp Physiol B (2017) 0.75
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Resveratrol improves health and survival of mice on a high-calorie diet. Nature (2006) 20.91
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
Effects of the obese gene product on body weight regulation in ob/ob mice. Science (1995) 13.57
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (1995) 9.09
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature (2004) 7.64
Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature (1997) 7.33
Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07
Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med (1999) 6.94
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron (2003) 6.05
Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science (2004) 5.98
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83
Trophic action of leptin on hypothalamic neurons that regulate feeding. Science (2004) 5.76
Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol (1998) 4.30
Obesity. N Engl J Med (2002) 4.29
From lesions to leptin: hypothalamic control of food intake and body weight. Neuron (1999) 4.18
Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest (2001) 3.82
A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science (2004) 3.54
The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab (2005) 3.38
Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron (1999) 3.37
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab (2006) 3.34
Leptin regulates striatal regions and human eating behavior. Science (2007) 3.31
Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med (2006) 3.24
Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A (2010) 3.23
Acute stimulation of glucose metabolism in mice by leptin treatment. Nature (1997) 3.12
Prospective association between obesity and depression: evidence from the Alameda County Study. Int J Obes Relat Metab Disord (2003) 2.95
Intracellular signalling pathways activated by leptin. Biochem J (2006) 2.93
Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes (1996) 2.83
Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A (1997) 2.57
Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care (2005) 2.44
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Inside the human cancer tyrosine phosphatome. Nat Rev Cancer (2011) 2.38
Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest (1998) 2.23
Sixteen years and counting: an update on leptin in energy balance. J Clin Invest (2011) 2.21
Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci U S A (1996) 2.15
Leptin regulation of neuroendocrine systems. Front Neuroendocrinol (2000) 2.12
Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A (2008) 2.12
Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab (2011) 1.99
Leptin and the central nervous system control of glucose metabolism. Physiol Rev (2011) 1.94
Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology (2009) 1.92
Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology (2011) 1.92
Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc Natl Acad Sci U S A (2007) 1.89
Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS One (2009) 1.88
Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab (2009) 1.79
Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes (1999) 1.79
Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology (2007) 1.78
Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci U S A (2003) 1.75
Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab (2007) 1.70
Leptin effects on pancreatic beta-cell gene expression and function. Diabetes (2004) 1.68
The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol (2007) 1.68
Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci U S A (2010) 1.66
The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J Clin Invest (2006) 1.62
Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients. Am J Physiol Endocrinol Metab (2008) 1.60
Maternal perinatal undernutrition drastically reduces postnatal leptin surge and affects the development of arcuate nucleus proopiomelanocortin neurons in neonatal male rat pups. Endocrinology (2007) 1.59
Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J (2004) 1.58
Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology (1999) 1.56
Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab (2006) 1.55
Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab (2003) 1.55
Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology (2010) 1.53
Impaired transport of leptin across the blood-brain barrier in obesity. Peptides (1999) 1.46
Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes (2010) 1.45
Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab (2005) 1.44
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol (2008) 1.44
Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci U S A (1999) 1.37
Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology (2002) 1.36
Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes (2012) 1.36
Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility. Am J Physiol Endocrinol Metab (2005) 1.35
Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes (2009) 1.33
Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology (2005) 1.29
Leptin replacement improves cognitive development. PLoS One (2008) 1.27
Leptin receptor signaling: pathways to leptin resistance. Front Biosci (Landmark Ed) (2011) 1.26
Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes (2000) 1.26
Ten years of leptin replacement therapy. Obes Rev (2011) 1.25
Minireview: Leptin and development of hypothalamic feeding circuits. Endocrinology (2004) 1.25
Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann N Y Acad Sci (2011) 1.22
Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci U S A (2004) 1.21
The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab (2009) 1.20
Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc Natl Acad Sci U S A (1996) 1.19
Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab (2000) 1.16
High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat. Diabetes Res Clin Pract (1996) 1.16
Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides (2009) 1.15
Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice. Am J Physiol (1999) 1.15
Role of leptin in the pancreatic β-cell: effects and signaling pathways. J Mol Endocrinol (2012) 1.15
Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels. Diabetes (2002) 1.11
Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes (2011) 1.10
Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature (2009) 1.10
Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite (2005) 1.10
Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes (2011) 1.10
Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Res (2002) 1.09
Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology (2010) 1.09
The relationship of obesity and obstructive sleep apnea. Clin Chest Med (2009) 1.08
Obesity: Be cool, lose weight. Nature (2009) 1.08
Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept (2001) 1.08
Intranasal leptin: blood-brain barrier bypass (BBBB) for obesity? Endocrinology (2006) 1.07
Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake. Endocrinology (2002) 1.07
Early postnatal leptin blockage leads to a long-term leptin resistance and susceptibility to diet-induced obesity in rats. Int J Obes (Lond) (2008) 1.06
Leptin does not directly affect CNS serotonin neurons to influence appetite. Cell Metab (2011) 1.04
Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes (2011) 1.03
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab (2006) 3.34
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology (2003) 2.14
Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer (2005) 1.65
Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (2003) 1.62
Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J (2004) 1.58
Anorexia in hemodialysis patients: the possible role of des-acyl ghrelin. Am J Nephrol (2007) 1.53
Impact of Helicobacter pylori eradication on circulating adiponectin in humans. Helicobacter (2012) 1.50
Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself. Nat Clin Pract Oncol (2005) 1.41
Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev (2009) 1.38
Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology (2005) 1.32
Is obesity an inflammatory disease? Surgery (2003) 1.26
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology (2007) 1.25
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology (2007) 1.23
Cancer cachexia--pathophysiology and management. J Gastroenterol (2013) 1.20
Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.18
Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab (2008) 1.18
Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides (2009) 1.15
Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care (2004) 1.15
Anorexia in space and possible etiologies: an overview. Nutrition (2002) 1.11
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry (2008) 1.09
Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol (2015) 1.08
Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol (2003) 1.03
Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides (2006) 1.03
Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg (2004) 1.02
Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry (2007) 1.01
Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology (2004) 0.99
Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res (2006) 0.98
Blunted metabolic response to fasting in obese mice. Endocrine (2007) 0.96
Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport (2010) 0.95
Anorexia in cancer: role of feeding-regulatory peptides. Philos Trans R Soc Lond B Biol Sci (2006) 0.95
Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides (2010) 0.95
A role for pancreatic polypeptide in feeding and body weight regulation. Peptides (2007) 0.94
Roles of pancreatic polypeptide in regulation of food intake. Peptides (2002) 0.93
Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development. FASEB J (2007) 0.91
Opioid μ-receptors as new target for insulin resistance. Pharmacol Ther (2013) 0.90
Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia. J Gastroenterol Hepatol (2011) 0.90
Localization of acyl ghrelin- and des-acyl ghrelin-immunoreactive cells in the rat stomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol (2009) 0.89
Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric (2011) 0.89
Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle. PLoS One (2013) 0.89
Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition (2011) 0.89
Melanin-concentrating hormone enhances sucrose intake. Int J Mol Med (2005) 0.89
Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice. World J Gastroenterol (2008) 0.89
Leptin treatment ameliorates anxiety in ob/ob obese mice. J Diabetes Complications (2003) 0.88
Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice. PLoS One (2013) 0.87
Chronic foot-shock stress potentiates the influx of bone marrow-derived microglia into hippocampus. J Neurosci Res (2010) 0.87
Ob/ob mice as a model of delayed gastric emptying. J Diabetes Complications (2002) 0.87
Branched-chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care (2005) 0.87
Control of food intake and muscle wasting in cachexia. Int J Biochem Cell Biol (2013) 0.86
The effect of mosapride citrate on constipation in patients with diabetes. Diabetes Res Clin Pract (2009) 0.86
Comparison of the anorexigenic activity of CRF family peptides. Biochem Biophys Res Commun (2009) 0.86
NPY and brain monoamines in the pathogenesis of cancer anorexia. Nutrition (2008) 0.86
Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa. Oncol Rep (2005) 0.86
Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry (2007) 0.85
Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Commun (2013) 0.85
Interleukin-1beta system in anorectic catabolic tumor-bearing rats. Curr Opin Clin Nutr Metab Care (2004) 0.85